发明名称 |
METABOLISM-BASED DRUG SCREENING PLATFORM IN BIOENGINEERED ZEBRAFISH |
摘要 |
The present application provides a novel drug screening platform designed to identify drugs that favorably modulate cellular bioenergetics in the human brain of a zebrafish which has been modified by altering a teleost gene that corresponds to a human gene associated with a brain dysfunction disorder (such as epilepsy). The drug screening platform are also useful for determining a mutation in a human gene associated with a brain dysfunction disorder that is associated with a human individual responsive to the treatment of a compound. Also provided are modified teleosts useful for the methods described herein. |
申请公布号 |
WO2015107431(A3) |
申请公布日期 |
2015.12.17 |
申请号 |
WO2015IB00644 |
申请日期 |
2015.01.16 |
申请人 |
PATH THERAPEUTICS, INC. |
发明人 |
KURRASCH, DEBORAH, M.;RHO, JOHN;IBHAZEHIEBO, KINGSLEY |
分类号 |
A01K67/027;C12Q1/00;C12Q1/68;C40B30/06 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|